VAG
RMD icon

VisionPoint Advisory Group’s ResMed RMD Stock Holding History

VisionPoint Advisory Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12
Closed -$2.3K – 658
2024
Q2 		$2.3K Hold
12
– – ﹤0.01% 654
2024
Q1 		$2.38K Buy
12
+2
+20% +$366 ﹤0.01% 652
2023
Q4 		$1.72K Sell
10
-8
-44% -$1.23K ﹤0.01% 644
2023
Q3 		$2.66K Buy
18
+16
+800% +$2.89K ﹤0.01% 566
2023
Q2 		$437 Buy
+2
New +$446 ﹤0.01% 548

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

VisionPoint Advisory Group's RMD Position: Q3 2024 in Review

VisionPoint Advisory Group sold out of ResMed (RMD) in Q3 2024, closing a stake of 12 shares — an estimated $2.3K sold.

VisionPoint Advisory Group first reported a position in RMD in Q2 2023 and held it in 5 quarters. The position peaked at $2.66K in Q3 2023. 801 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

  • VisionPoint Advisory Group reported no remaining ResMed position as of Q3 2024 after selling out during the quarter.
  • VisionPoint Advisory Group sold 12 ResMed shares in Q3 2024, an estimated $2.3K.
  • VisionPoint Advisory Group first reported a position in ResMed in Q2 2023 and held it in 5 quarters.
  • VisionPoint Advisory Group's ResMed position peaked at $2.66K in Q3 2023.
  • 801 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on VisionPoint Advisory Group's 13F filing for Q3 2024, filed 15 Oct 2024.